CA Stock MarketDetailed Quotes

MDP Medexus Pharmaceuticals Inc

Watchlist
  • 2.260
  • +0.050+2.26%
15min DelayMarket Closed Jul 19 16:00 ET
55.28MMarket Cap-161428P/E (TTM)

Medexus Pharmaceuticals Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
(Q1)Jun 30, 2022
Total revenue
4.59%113.05M
-9.33%25.96M
-12.25%25.21M
9.54%30.33M
36.92%31.56M
40.93%108.1M
41.31%28.63M
35.08%28.73M
54.66%27.69M
33.47%23.05M
Operating revenue
4.59%113.05M
-9.33%25.96M
-12.25%25.21M
9.54%30.33M
36.92%31.56M
40.93%108.1M
41.31%28.63M
35.08%28.73M
54.66%27.69M
33.47%23.05M
Cost of revenue
11.41%53.54M
-7.04%12.66M
-2.19%12.52M
21.71%14.05M
41.72%14.32M
23.94%48.06M
34.16%13.62M
31.01%12.8M
35.58%11.54M
-2.33%10.1M
Gross profit
-0.87%59.51M
-11.40%13.31M
-20.34%12.69M
0.83%16.28M
33.17%17.24M
58.30%60.04M
48.48%15.02M
38.54%15.93M
71.96%16.14M
86.94%12.94M
Operating expense
-9.35%46.73M
-14.03%10.48M
-12.13%11.13M
-7.90%12.72M
-3.76%12.4M
2.48%51.55M
12.71%12.19M
7.23%12.66M
1.62%13.82M
-8.54%12.88M
Selling and administrative expenses
-8.84%38.44M
-12.27%8.64M
-11.95%9.12M
-8.67%10.29M
-2.85%10.39M
9.24%42.16M
20.84%9.85M
10.41%10.35M
8.16%11.26M
0.40%10.7M
-Selling and marketing expense
-7.13%10.58M
-19.97%2.12M
1.52%2.61M
-3.74%2.91M
-6.62%2.93M
19.78%11.39M
50.28%2.65M
25.48%2.57M
28.40%3.03M
-5.93%3.14M
-General and administrative expense
-9.47%27.86M
-9.43%6.52M
-16.40%6.51M
-10.48%7.37M
-1.28%7.46M
5.80%30.77M
12.70%7.2M
6.20%7.78M
2.25%8.24M
3.30%7.55M
Research and development costs
-10.99%8.04M
-21.73%1.78M
-12.17%1.95M
-3.63%2.37M
-6.75%1.95M
-20.13%9.03M
-11.78%2.27M
-5.09%2.22M
-20.73%2.46M
-36.72%2.09M
Depreciation amortization depletion
-28.90%251K
-11.76%60K
-32.22%61K
-26.53%72K
-40.21%58K
-11.31%353K
-23.60%68K
-3.23%90K
13.95%98K
-25.38%97K
-Depreciation and amortization
-28.90%251K
-11.76%60K
-32.22%61K
-26.53%72K
-40.21%58K
-11.31%353K
-23.60%68K
-3.23%90K
13.95%98K
-25.38%97K
Operating profit
50.63%12.79M
-0.07%2.83M
-52.08%1.57M
52.60%3.55M
7,834.43%4.84M
168.59%8.49M
503.28%2.83M
1,169.28%3.27M
155.36%2.33M
100.85%61K
Net non-operating interest income (expenses)
1.78%-13.36M
38.43%-2.22M
25.23%-2.66M
-28.42%-4.23M
-35.12%-4.26M
-11.31%-13.61M
-16.25%-3.61M
-12.41%-3.55M
-7.19%-3.29M
-9.19%-3.15M
Non-operating interest expense
-1.78%13.36M
-38.43%2.22M
-25.23%2.66M
28.42%4.23M
35.12%4.26M
11.31%13.61M
16.25%3.61M
12.41%3.55M
7.19%3.29M
9.19%3.15M
Other net income (expenses)
798.68%683K
-51.19%389K
143.09%293K
81.10%-298K
-80.53%299K
-99.63%76K
300.50%797K
-130.60%-680K
-110.58%-1.58M
-55.59%1.54M
Gain on sale of security
-109.83%-83K
-148.15%-377K
195.13%293K
75.06%-298K
-80.88%299K
-95.97%844K
272.47%783K
-113.66%-308K
-107.62%-1.2M
-54.78%1.56M
Special income (charges)
199.74%766K
5,371.43%766K
--0
--0
--0
-368.29%-768K
-97.86%14K
-1,027.27%-372K
51.28%-382K
---28K
-Less:Restructuring and mergern&acquisition
-315.36%-1.65M
-11,714.29%-1.65M
--0
--0
--0
148.42%768K
99.42%-14K
1,027.27%372K
-51.28%382K
--28K
-Less:Impairment of capital assets
--888K
----
----
----
----
--0
----
----
----
----
Income before tax
102.10%106K
8,150.00%990K
17.19%-795K
61.71%-973K
156.96%884K
-31.96%-5.04M
100.33%12K
22.83%-960K
-133.35%-2.54M
76.44%-1.55M
Income tax
105.11%320K
103.33%228K
-147.71%-261K
-36.51%120K
251.30%233K
-565.46%-6.26M
-507.87%-6.84M
681.91%547K
107.49%189K
-154K
Earnings from equity interest net of tax
Net income
-117.53%-214K
-88.89%762K
64.57%-534K
59.96%-1.09M
146.57%651K
142.41%1.22M
229.68%6.86M
-31.04%-1.51M
-126.91%-2.73M
78.78%-1.4M
Net income continuous operations
-117.53%-214K
-88.89%762K
64.57%-534K
59.96%-1.09M
146.57%651K
142.41%1.22M
229.68%6.86M
-31.04%-1.51M
-126.91%-2.73M
78.78%-1.4M
Noncontrolling interests
Net income attributable to the company
-117.53%-214K
-88.89%762K
64.57%-534K
59.96%-1.09M
146.57%651K
142.41%1.22M
229.68%6.86M
-31.04%-1.51M
-126.91%-2.73M
78.78%-1.4M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-117.53%-214K
-88.89%762K
64.57%-534K
59.96%-1.09M
146.57%651K
142.41%1.22M
229.68%6.86M
-31.04%-1.51M
-126.91%-2.73M
78.78%-1.4M
Diluted earnings per share
-116.67%-0.01
-88.24%0.04
71.43%-0.02
64.29%-0.05
142.86%0.03
140.00%0.06
225.93%0.34
0.00%-0.07
-126.42%-0.14
79.41%-0.07
Basic earnings per share
-116.67%-0.01
-88.24%0.04
71.43%-0.02
64.29%-0.05
142.86%0.03
140.00%0.06
225.93%0.34
0.00%-0.07
-126.92%-0.14
79.41%-0.07
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(Q2)Sep 30, 2022(Q1)Jun 30, 2022
Total revenue 4.59%113.05M-9.33%25.96M-12.25%25.21M9.54%30.33M36.92%31.56M40.93%108.1M41.31%28.63M35.08%28.73M54.66%27.69M33.47%23.05M
Operating revenue 4.59%113.05M-9.33%25.96M-12.25%25.21M9.54%30.33M36.92%31.56M40.93%108.1M41.31%28.63M35.08%28.73M54.66%27.69M33.47%23.05M
Cost of revenue 11.41%53.54M-7.04%12.66M-2.19%12.52M21.71%14.05M41.72%14.32M23.94%48.06M34.16%13.62M31.01%12.8M35.58%11.54M-2.33%10.1M
Gross profit -0.87%59.51M-11.40%13.31M-20.34%12.69M0.83%16.28M33.17%17.24M58.30%60.04M48.48%15.02M38.54%15.93M71.96%16.14M86.94%12.94M
Operating expense -9.35%46.73M-14.03%10.48M-12.13%11.13M-7.90%12.72M-3.76%12.4M2.48%51.55M12.71%12.19M7.23%12.66M1.62%13.82M-8.54%12.88M
Selling and administrative expenses -8.84%38.44M-12.27%8.64M-11.95%9.12M-8.67%10.29M-2.85%10.39M9.24%42.16M20.84%9.85M10.41%10.35M8.16%11.26M0.40%10.7M
-Selling and marketing expense -7.13%10.58M-19.97%2.12M1.52%2.61M-3.74%2.91M-6.62%2.93M19.78%11.39M50.28%2.65M25.48%2.57M28.40%3.03M-5.93%3.14M
-General and administrative expense -9.47%27.86M-9.43%6.52M-16.40%6.51M-10.48%7.37M-1.28%7.46M5.80%30.77M12.70%7.2M6.20%7.78M2.25%8.24M3.30%7.55M
Research and development costs -10.99%8.04M-21.73%1.78M-12.17%1.95M-3.63%2.37M-6.75%1.95M-20.13%9.03M-11.78%2.27M-5.09%2.22M-20.73%2.46M-36.72%2.09M
Depreciation amortization depletion -28.90%251K-11.76%60K-32.22%61K-26.53%72K-40.21%58K-11.31%353K-23.60%68K-3.23%90K13.95%98K-25.38%97K
-Depreciation and amortization -28.90%251K-11.76%60K-32.22%61K-26.53%72K-40.21%58K-11.31%353K-23.60%68K-3.23%90K13.95%98K-25.38%97K
Operating profit 50.63%12.79M-0.07%2.83M-52.08%1.57M52.60%3.55M7,834.43%4.84M168.59%8.49M503.28%2.83M1,169.28%3.27M155.36%2.33M100.85%61K
Net non-operating interest income (expenses) 1.78%-13.36M38.43%-2.22M25.23%-2.66M-28.42%-4.23M-35.12%-4.26M-11.31%-13.61M-16.25%-3.61M-12.41%-3.55M-7.19%-3.29M-9.19%-3.15M
Non-operating interest expense -1.78%13.36M-38.43%2.22M-25.23%2.66M28.42%4.23M35.12%4.26M11.31%13.61M16.25%3.61M12.41%3.55M7.19%3.29M9.19%3.15M
Other net income (expenses) 798.68%683K-51.19%389K143.09%293K81.10%-298K-80.53%299K-99.63%76K300.50%797K-130.60%-680K-110.58%-1.58M-55.59%1.54M
Gain on sale of security -109.83%-83K-148.15%-377K195.13%293K75.06%-298K-80.88%299K-95.97%844K272.47%783K-113.66%-308K-107.62%-1.2M-54.78%1.56M
Special income (charges) 199.74%766K5,371.43%766K--0--0--0-368.29%-768K-97.86%14K-1,027.27%-372K51.28%-382K---28K
-Less:Restructuring and mergern&acquisition -315.36%-1.65M-11,714.29%-1.65M--0--0--0148.42%768K99.42%-14K1,027.27%372K-51.28%382K--28K
-Less:Impairment of capital assets --888K------------------0----------------
Income before tax 102.10%106K8,150.00%990K17.19%-795K61.71%-973K156.96%884K-31.96%-5.04M100.33%12K22.83%-960K-133.35%-2.54M76.44%-1.55M
Income tax 105.11%320K103.33%228K-147.71%-261K-36.51%120K251.30%233K-565.46%-6.26M-507.87%-6.84M681.91%547K107.49%189K-154K
Earnings from equity interest net of tax
Net income -117.53%-214K-88.89%762K64.57%-534K59.96%-1.09M146.57%651K142.41%1.22M229.68%6.86M-31.04%-1.51M-126.91%-2.73M78.78%-1.4M
Net income continuous operations -117.53%-214K-88.89%762K64.57%-534K59.96%-1.09M146.57%651K142.41%1.22M229.68%6.86M-31.04%-1.51M-126.91%-2.73M78.78%-1.4M
Noncontrolling interests
Net income attributable to the company -117.53%-214K-88.89%762K64.57%-534K59.96%-1.09M146.57%651K142.41%1.22M229.68%6.86M-31.04%-1.51M-126.91%-2.73M78.78%-1.4M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -117.53%-214K-88.89%762K64.57%-534K59.96%-1.09M146.57%651K142.41%1.22M229.68%6.86M-31.04%-1.51M-126.91%-2.73M78.78%-1.4M
Diluted earnings per share -116.67%-0.01-88.24%0.0471.43%-0.0264.29%-0.05142.86%0.03140.00%0.06225.93%0.340.00%-0.07-126.42%-0.1479.41%-0.07
Basic earnings per share -116.67%-0.01-88.24%0.0471.43%-0.0264.29%-0.05142.86%0.03140.00%0.06225.93%0.340.00%-0.07-126.92%-0.1479.41%-0.07
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
%Chg